在多发性硬化症患者的常规临床护理中获得的纳塔利祖马布血清度的分析:一个横截面研究

D Moskorova1, I Kacirova1, P Hradilek2

  • 1Department of Clinical Pharmacology, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic; Department of Clinical Pharmacology, Institute of Laboratory Medicine, University Hospital Ostrava, 17. listopadu 1790, 708 52 Ostrava, Czech Republic.

概括

纳塔利祖马布的血清度在多发性硬化症患者中差异很大,即使在相同剂量下也是如此. 这种变化可能会增加不良事件的风险或降低治疗的有效性.